(Q41596334)

4 October 2017

Persistence of anti-hypertensive effect after missed dose of perindopril (English)

1 reference

4 October 2017

Tan KW

1

1 reference

4 October 2017

Leenen FH

series ordinal

2

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

British Journal of Clinical Pharmacology

4 October 2017

1 reference

4 October 2017

48

1 reference

4 October 2017

4

1 reference

4 October 2017

628-630

1 reference

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators

4 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014367

Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring

6 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014367

Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients

6 June 2018

1 reference

12 December 2020

Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life

1 reference

12 December 2020

Beta-blockade disappearance rate predicts beta-adrenergic hypersensitivity

1 reference

12 December 2020

Therapeutic implications of drug "holidays'

1 reference

12 December 2020

Intermittent blood pressure control: Potential consequences for outcome

1 reference

12 December 2020

Mortality in patients of the Glasgow Blood Pressure Clinic

1 reference

12 December 2020

A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00055.X

Identifiers

DOI

1 reference

4 October 2017

1 reference

4 October 2017

PubMed publication ID

10583036

1 reference